Syed A Ahmed
Overview
Explore the profile of Syed A Ahmed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
329
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Furqan A, Ahmed S, Naeem R, Ashfaq M
Genet Med Open
. 2024 Dec;
2(Suppl 2):101883.
PMID: 39712958
No abstract available.
2.
Wu B, Chen Q, Moon B, Lustigova E, Nielsen E, Alvarado M, et al.
Clin Transl Gastroenterol
. 2023 Oct;
15(1):e00650.
PMID: 37800692
Introduction: Screening for pancreatic cancer (PC) is suggested for high-risk individuals. Additional risk factors may enhance early detection in this population. Methods: Retrospective cohort study among patients with germline variants...
3.
Ashfaq M, Ahmed S, Aziz-Rizvi R, Hasan Z, Kirmani S, Munim S, et al.
J Community Genet
. 2022 Oct;
14(1):71-80.
PMID: 36264421
While the prevalence of genetic disorders has been well documented in the Muslim-majority, low-socioeconomic country of Pakistan, the provision of medical genetic services remains limited and cost-prohibitive to the masses...
4.
Koh V, Chakrabarti J, Torvund M, Steele N, Hawkins J, Ito Y, et al.
Cancer Lett
. 2021 Jun;
518:59-71.
PMID: 34126195
Tumors evade immune surveillance by expressing Programmed Death-Ligand 1 (PD-L1), subsequently inhibiting CD8 cytotoxic T lymphocyte function. Response of gastric cancer to immunotherapy is relatively low. Our laboratory has reported...
5.
Huffmeier U, Kraus C, Reuter M, Uebe S, Abbott M, Ahmed S, et al.
Orphanet J Rare Dis
. 2021 Mar;
16(1):136.
PMID: 33736665
Background: An identical homozygous missense variant in EIF3F, identified through a large-scale genome-wide sequencing approach, was reported as causative in nine individuals with a neurodevelopmental disorder, characterized by variable intellectual...
6.
Haque R, Shi J, Chung J, Xu X, Avila C, Campbell C, et al.
J Am Pharm Assoc (2003)
. 2017 Mar;
57(3):303-310.e2.
PMID: 28259737
Objective: Our objective was to examine the association between adherence to tyrosine kinase inhibitors (TKIs) and molecular monitoring and the risk of disease progression or mortality among patients with chronic...
7.
Hossain A, Tauhid L, Davenport I, Huckaba T, Graves R, Mandal T, et al.
Curr Eye Res
. 2016 Jul;
42(4):640-647.
PMID: 27442082
Purpose: The cell surface LDL (low-density lipoprotein) receptor-related protein-1 (LRP-1) is important for lipid transport and several cell signaling processes. Human apolipoprotein E (apoE) is a ligand of LRP-1. We...
8.
Haque R, Shi J, Schottinger J, Ahmed S, Cheetham T, Chung J, et al.
J Natl Cancer Inst
. 2015 Dec;
108(3).
PMID: 26631176
Background: Controversy persists about whether certain antidepressants reduce tamoxifen's effectiveness on lowering breast cancer recurrence. We investigated whether taking tamoxifen and antidepressants (in particular, paroxetine) concomitantly is associated with an...
9.
Kumar R, Kukreja R, Li L, Zhmurov A, Kononova O, Cai S, et al.
J Biomol Struct Dyn
. 2013 Jun;
32(5):804-15.
PMID: 23746226
Botulinum neurotoxin (BoNT), the most toxic substance known to mankind, is the first example of the fully active molten globule state. To understand its folding mechanism, we performed urea denaturation...
10.
Haque R, Ahmed S, Fisher A, Avila C, Shi J, Guo A, et al.
Cancer Med
. 2013 Jan;
1(3):318-27.
PMID: 23342281
Tamoxifen (TAM) has been prescribed for decades and aromatase inhibitors (AIs) have been used since the early 2000s in preventing subsequent breast cancer. However, outside of clinical trials, the effectiveness...